











































































































being	 the	 synthesis	 of	 proteins,	 ribosomal	 proteins	 included.	 Ribosome	 biogenesis	 is	 the	
process	by	which	the	different	elements	forming	the	two	ribosomal	subunits	are	synthesized	
and	assembled.	Since	almost	all	cellular	activities	depend	on	the	protein	synthesis	capacity	of	






The	present	work	aims	 to	overview	the	 factors	 that	 lead	 to	 the	activation	of	 the	 Impaired	
Ribosome	Biogenesis	Checkpoint,	as	well	as	the	main	pathologies	derived	from	its	activation	










tipus	 de	 cèl·lules,	 i	 la	 seva	 funció	 principal	 és	 la	 síntesi	 de	 proteïnes,	 incloent	 les	 pròpies	
proteïnes	 ribosomals	 que	 els	 formen.	 La	 biogènesi	 ribosomal	 és	 el	 procés	 pel	 qual	 es	
sintetitzen	els	diferents	elements	que	més	tard	conformaran	les	dues	subunitats	ribosomals.	
Donat	que	una	gran	part	de	l’activitat	cel·lular	depèn	de	la	capacitat	de	síntesi	proteica	de	la	









o	 inactivació	 (ribosomopaties	 i	 càncer),	 i	 també	s’estudiarà	 l’impacte	de	 la	 traducció	en	el	













Biochemistry	and	molecular	biology	 is	 the	main	 field	of	 this	assignment.	 It	has	allowed	to	
describe	the	processes	and	pathways	of	ribosome	biogenesis	and	its	impairment,	as	well	as	
the	methods	used	for	its	study.	This	field	has	also	contributed	to	explaining	and	linking	the	

















Ribosomes	 are	 the	 ribonucleoprotein	 complexes	 responsible	 of	 decoding	 the	 genetic	
information	 into	proteins	and	accountable	 for	 the	production	of	 the	cellular	biomass.	This	
basic	 cellular	 function	 is	 essential	 for	 life[1],	 explaining	 why	 ribosomes	 are	 universally	








In	 eukaryotes,	 ribosomes	 can	 also	 be	 found	 attached	 to	 the	 endoplasmic	 reticulum	 (ER),	
translating	 mRNAs	 that	 encode	 for	 proteins	 destined	 to	 a	 number	 of	 different	 cellular	
functions,	 for	 example,	 the	 ones	 that	 will	 transit	 through	 the	 secretory	 pathway[2].	
Importantly,	 a	 single	 mRNA	 molecule	 can	 be	 translated	 by	 many	 ribosomes	 that	




As	 stated	before,	 ribosomes	are	 formed	by	about	80	proteins,	 termed	Ribosomal	Proteins	












the	 life	 cycle	 of	 a	 cell,	 required	 for	 a	 correct	 cellular	 activity	 and	 function.	 It	 starts	 in	 the	
nucleolus,	a	special	compartment	within	the	nucleus[3],	and	requires	four	different	kinds	of	
rRNAs,	 about	 80	RPs	 and	 the	 activity	 of	 three	RNA	polymerases,	 alongside	 a	 considerable	
number	of	accessory	factors	and	small	nucleolar	RNAs	(snoRNAs).	
	
Ribosomal	 Proteins	 (RPs),	 are	 a	 family	 of	 RNA	 binding	 proteins	 and	 constitute	 a	 core	
component	of	the	ribosome,	playing	a	leading	role	in	mRNA	translation.	The	multiple	roles	of	




























and	 a	 diameter	 of	 22nm.	 They	 are	 formed	 by	 two	 ribonucleoprotein	 subunits:	 the	 large	






































However,	 there	 is	 an	 alternative	mode	 of	 translation	 initiation,	 named	 Internal	 Ribosome	





In	 some	 physiological	 and	 pathophysiological	 conditions,	 IRES-dependent	 translation	 is	
stimulated,	supporting	a	robust	translation	of	mRNAs	when	the	cap-dependent	pathway	 is	
compromised	or	suppressed.	Diverse	studies	over	the	last	years	have	found	that	many	mRNAs	
containing	 IRES	 elements	 within	 their	 5’UTR	 actually	 encode	 proteins	 involved	 in	 stress	








of	 its	 stabilization,	p53	can	operate	and	arrest	 the	cell	 cycle,	or	 induce	a	programmed	cell	
death	 (apoptosis).	 In	 addition	 to	 the	 above	 mentioned	 roles,	 upon	 a	 defined	 biological	
context,	p53	expression	 can	determine	 the	 induction	of	 senescence	or	a	 switch	 in	 cellular	
metabolism.	A	crucial	step	in	the	activation	of	p53	is	its	stabilization.	Under	normal	conditions,	
p53	 is	 efficiently	 ubiquitinated	 and	 degraded,	 resulting	 in	 its	 short	 half	 life.	 In	 contrast,	
following	 exposure	 of	 cells	 to	 stress,	 the	 levels	 of	 p53	 increase,	 predominantly	 due	 to	 its	






The	 first	 evidence	 for	 the	 existence	 of	 a	 cell	 cycle	 checkpoint	 in	 higher	 eukaryotes	 that	
responds	 to	 impaired	 ribosome	biogenesis	 came	 from	 studies	 in	out	 laboratory.	 The	 gene	
	 9	
encoding	 ribosomal	protein	RPS6	was	 conditionally	deleted	 in	 the	 liver	of	 adult	mice	and,	
following	partial	hepatectomy,	hepatocytes	failed	to	re-enter	the	cell	cycle	and	proliferate[4].	
Subsequent	studies	demonstrated	that	this	hindrance	in	proliferation	is	due	to	the	activation	
of	 a	 p53-dependent	 checkpoint	 that	 is	 triggered	 by	 a	 specific	 pre-ribosomal	 complex	






5S	 rRNA	 is	also	 involved	 in	 the	 regulation	of	another	 component	of	 the	p53	pathway;	 the	
transcriptional	 regulator	 HdmX.	 In	 normal	 conditions,	 the	 formation	 of	 the	 Hdm2-HdmX	
heterodimer	 represses	 the	 transcriptional	 activity	 of	 p53	 and	 promotes	 its	
polyubiquitinization	and	degradation.	The	binding	of	RPL11	to	Hdm2,	besides	blocking	its	E3-
ligase	 activity,	 also	 facilitates	 HdmX	 degradation,	 strengthening	 p53’s	 hyperactivation.	





















factors,	 as	 mentioned	 above.	 Deregulation	 of	 Myc	 activity	 is	 one	 of	 the	 most	 frequent	




stimulation	 of	 ribosome	 biogenesis.	 Indeed,	 uncontrolled	 proliferation,	 a	 hallmark	 of	 all	





Recent	evidence	 suggests	 that	 the	RPL5-RPL11-Hdm2-p53	pathway	may	monitor	excessive	
ribosome	biogenesis	to	prevent	tumorigenesis[9].	c-Myc,	as	the	regulator	of	the	45/47S	pre-
rRNA,	 5S	 rRNA	 and	 all	 RP	 mRNA	 transcription,	 becomes	 directly	 associated	 to	 ribosome	
biogenesis.	 Several	 experiments	 carried	 out	 using	 mouse	 models	 of	 B-cell	 lymphoma	
predisposition	overexpressing	c-Myc[13]	demonstrated	how	c-Myc	is	capable	of	upregulating	
ribosome	 biogenesis	 in	 this	 tumor	 context.	 An	 RPL24-haploinsufficiency	 background,	 that	
reduces	 the	 ribosome	 production	 and	 the	 protein	 synthetic	 capacity	 of	 B-cell	 to	 a	
premalignant	 state,	 dramatically	 reduces	 the	 tumorigenic	 burden	 determined	 by	 c-Myc	










A	 category	of	 anemic	 syndromes	 like	Diamond	Blackfan	Anemia	 (DBA),	 5q–	 syndrome	and	
Schwachman	 Diamond	 Syndrome	 (SDS),	 characterized	 by	 bone	 marrow	 failure,	 growth	
retardation	 and	 cancer	 later	 in	 life,	 are	 associated	with	 haploinsufficient	mutation	 in	 RPs	




activation	 of	 p53	 IRBC-dependent	 underlies	 the	 pathogenesis	 of	 the	 human	 DBA,	 5q–	
syndrome	and	SDS[15].	Conditional	deletion	of	RPS6	in	mouse	bone	marrow	can	recapitulate	
the	 features	 of	 DBA.	 Intriguingly,	 p53-/-	 background	 can	 rescue	 most	 of	 the	 phenotypes	
associated	with	DBA,	underscoring	the	role	of	p53	checkpoint[16].	





protein	 translation	process[15].	 In	case	of	having	a	 reduction	 in	 the	number	of	 ribosomes,	
there’s	a	competition	between	different	kinds	of	mRNAs.	In	this	situation,	TOP	mRNAs	come	
into	play.	mRNAs	containing	a	5’TOP	sequence	at	the	5’UTR	region	have	a	higher	affinity	for	
specific	 translational	 machinery	 than	 the	 ones	 lacking	 it.	 We	 must	 remember	 that	 these	
mRNAs	 usually	 codify	 for	 almost	 all	 RPs	 and	many	 translational	 factors,	 as	 stated	 before.	
Qualitative	defects	 in	 ribosomes	might	affect	 the	 translation	of	 specific	 target	mRNAs[15].	





(associated	 with	 a	 high	 ribosome	 production	 rate),	 such	 as	 bone	marrow.	 Of	 course,	 the	
degree	 of	 damage	 in	 ribosome	 synthesis	 caused	 by	 any	mutation	 affecting	 a	 component	






As	 it	was	mentioned	before,	DBA	 is	 a	 congenital	disease	 that	 leads	 to	macrocytic	anemia,	
caused	by	the	reduction	of	erythroid	precursors	in	bone	marrow[15,17].	About	half	of	these	














Several	 studies	have	addressed	 the	 link	between	 the	 translation	of	 5’TOP	mRNAs	and	 the	
mTOR	 pathway,	 such	 as	 upon	 mTOR	 inhibition[20],	 or	 under	 aminoacid	 deprivation[21].	
Recently,	 the	 RNA	 binding	 protein	 LARP1,	 a	 protein	 belonging	 to	 the	 La-related	 family	 of	




















proliferate,	 can	 rapidly	 control	 the	production	of	 biomass	 required	 for	 cell	 duplication,	 by	
stimulating	 the	 translation	of	RP	mRNAs	and	hence	 the	production	of	more	 ribosomes.	 In	












The	present	work	 is	mainly	based	on	 the	 collection	of	bibliographic	 information	extracted	
from	 PubMed	 and	 Scopus	 databases.	 The	 initial	 search	 terms	 in	 the	 first	 screening	 were	
ribosome	biogenesis	and	cancer.	This	initial	selection	provided	a	set	of	scientific	articles	that	
leaded	to	other	articles,	by	 looking	at	the	citations	within	their	bibliography.	This	step	was	






























1.	 Preparation	 of	 solutions.	 In	 this	 step,	 basic	 solution	 and	 two	 sucrose	 solutions	 with	




tubes	are	placed	 in	a	 fitting	 rack	on	a	 steady	 surface,	allowing	 the	 layering	of	 the	 sucrose	
solutions.	 Two	 syringes	 are	 filled	 with	 the	 two	 different	 sucrose	 solutions,	 respectively.	
Afterwards,	a	specific	volume	of	the	sucrose	solutions	(starting	with	the	10%	solutions	and	
following	with	the	50%	solution)	are	added	to	the	bottom	of	the	tubes.	It	is	important	to	avoid	





















gradient	 (10%	 sucrose)	 and	 proceeding	 till	 the	 bottom	 of	 the	 tube	 (50%	 sucrose).	 	While	
fractionating	 the	 gradient	 into	 1ml	 aliquots,	 the	 sucrose	 solution	 is	 read	 by	 the	
spectrophotometer	 which	 generate	 a	 profile	 of	 rRNA	 absorbance	 across	 the	 gradient.	 	 A	
sample	from	each	fraction	is	stored	for	following	RNA	analysis.		
	
6.	 Isolation	 of	 RNA	 from	 sucrose	 fractions.	 Equal	 amounts	 of	 phenol:chloroform:isoamyl	
alcohol	are	added	to	each	sucrose	fraction	to	remove	proteins.	After	several	centrifugations	
and	removal	of	the	phenolic	phase,	the	fractions	are	added	with	one	volume	of	Isopropanol	
and	 left	 overnight	 at	 -20ºC	 for	 precipitation.	 The	 following	day,	 RNA	pellet	 is	 obtained	by	
centrifugation,	washed,	air	dried,	and	finally	resuspended	with	RNase-free	water.		
The	RNA	derived	from	each	fraction	is	then	analyzed	by	Northern	Blot	or	RT-qPCR	analyses	









seq	 approaches,	 has	 allowed	 to	 characterize	 unbiasedly	 the	 expression	 profile	 in	 a	 huge	
number	of	biological	contexts,	either	physiological	and	pathological.	This	approach	has	been	
of	 fundamental	 importance	 to	 broaden	 the	 point	 of	 view	 of	 researchers	 from	 the	 single	





mechanisms	 that	 control	 their	 translation.	 Many	 recent	 studies	 have	 demonstrated	 in	




















free	 40S,	 free	 60S	 subunits,	 and	 80S	 monosomes	 (Figure	 2).	 Downstream	 of	 polysomal	
fractionation,	 RTq-PCR	 and	 Northern	 Blot	 are	 two	 standard	 techniques	 that	 are	 usually	
implemented	to	monitor	and	quantify	the	distribution	of	different	mRNAs	within	the	gradient.	








known[27].	 For	 instance,	 Damgaard	 and	 coworkers[28]	 used	 polysome	 profiling	 to	
demonstrate	that	the	RNA	binding	proteins	TIA-1	and	TIAR	can	associate	to	5’TOP	mRNAs	by	
binding	to	their	5’	element	when	cells	are	cultured	in	absence	of	amino	acids.	The	authors	
show	 that	 this	 association	 determines	 a	 release	 of	 these	 transcripts	 from	 polysomes	 and	
hence,	a	reduction	in	the	synthesis	of	the	cognate	proteins.	The	team	quantified	the	levels	of	
three	specific	mRNAs	containing	the	5’TOP	sequence	(RPL23a,	RPL12/36	and	PABPC1)	in	the	
polysomal	 fractions	 upon	 aminoacid	 starvation.	 β-actin	 and	 calmodulin	 2	 mRNAs	 (lacking	
5’TOP	sequence	but	containing	a	binding	site	for	TIA-1	and	TIAR	at	their	3’	end)	were	used	as	
	 20	









and	 arduous	method	 requires	 specialized	 equipment	 that	may	 not	 be	 accessible	 to	 every	








Ingolia	 and	 Jonathan	Weissman	 at	 UCSF[29]	 and	 enables	 determining	 the	 engagement	 in	
translation	at	a	global	level	of	the	whole	transcriptome	of	a	cell	and	the	position	of	ribosomes	






that	 is	 not	 protected	 by	 ribosome	 occupancy,	 is	 exposed	 to	 RNAse	 activity	 and	 is	 then	
degraded.	 Under	 this	 setting,	 the	 ribosome	 protection	 generates	 footprints	 in	 the	 whole	











This	 powerful	 approach	 has	 led	 to	 the	 discovery	 of	 novel	 coding	 transcripts,	 new	 protein	
isoforms	and	the	accurate	determination	of	elongation	and	decoding	speeds,	among	many	
other	 features	 and	 functions.	 Furthermore,	 the	 possibility	 of	 discerning	 the	 initiation	 and	
elongation	events	allowed	the	discovery	of	countless	new	uORFs	and	alternative	start	codons	
involved	with	ribosomes[30].	This	is	the	case	of	a	study	by	Hsieh	and	coworkers[31]	in	PC3	
cells,	 where	 ribosome	 profiling	 was	 used	 to	 compare	 the	 effect	 of	 two	 mTOR	 inhibitors	
(rapamycin	and	PP242)	over	a	3h	treatment	period	through	the	sequencing	of	RPFs	(ribosome	
protected	fragments).	The	method	enabled	the	determination	of	mRNA	abundance	(RNA-seq	
reads),	 ribosome	 occupancy	 (RPF	 reads)	 and	 translational	 efficiency	 (RPF	 reads/RNA-seq	
reads).	 Data	 treatment	 revealed	 a	 significant	 higher	 number	 of	 target	 mRNAs	 selectively	
decreased	at	the	translational	level	upon	PP242	treatment	compared	to	rapamycin	treatment,	
as	shown	in	figure	5,	meaning	a	higher	effectiveness	for	mTOR	inhibition.	Moreover,	ribosome	
profiling	 revealed	 the	 presence	 of	 two	 regulatory	 motives	 within	 the	 5’UTR	 sequence	 of	
mTOR-sensitive	mRNAs:	68%	of	them	contained	a	5’TOP	sequence,	against	63%	containing	
PRTE	 (pyrimidine-rich	 translational	 element).	 When	 looking	 for	 5’TOP	 and	 PRTE	 together	
within	the	same	5’UTR,	it	was	found	that	89%	of	the	target	mRNAs	contained	both	sequences,	









Finally,	 translationally	 regulated	mTOR-sensitive	mRNAs	were	 classified	 according	 to	 their	
function.	 Among	 all	 the	 different	 functions,	 protein	 synthesis	 and	 cell	 invasion/metastasis	




Even	 though	 ribosome	profiling	 is	 presented	 as	 a	 powerful	 technique,	 it	 is	 not	 exempt	 of	
limitations.	As	with	polysome	profiling,	specialized	equipment	is	required,	and	the	complex	








blocking	 many	 steps	 of	 ribosome	 biogenesis	 capacity	 of	 the	 cell.	 RPs	 synthesis	 is	 mainly	
controlled	at	the	translational	level,	and	mTOR	signaling	is	in	charge	of	sustaining	RP	mRNA	
translation	 by	 virtue	 of	 the	 5’TOP	 sequence	 element	 that	 almost	 all	 RPs	 possess	 at	 the	








full	 medium	 supplemented	 with	 the	 mTORC1	 allosteric	 inhibitor	 rapamycin,	 at	 the	
concentration	 of	 40nM	 for	 16h.	 Cells	 were	 harvested	 and	 polysomal	 lysates	 prepared	
according	to	the	protocol	described	above.	Equal	amounts	of	polysomal	lysates	were	applied	










































mRNAs	 in	 HTC116	 cancer	 cells.	 As	 almost	 all	 RPs	 (including	 RPL11)	 contain	 this	 5’TOP	
sequence,	 this	 effect	 negatively	 impacts	 the	 synthesis	 RPs	 and	 hence	 of	 ribosomes,	 and	
consequently	slow	down	the	proliferation	rate	of	cancer	cells.	This	effect	can	be	measured	by	
using	the	polysome	profiling	technique.	
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